1. Home
  2. Healthcare
  3. Neurofibromatosis Pipeline Analysis 2018

Neurofibromatosis Pipeline Analysis 2018 - Focusing On Clinical Trials And Results, Drug Profiling, Patents, Collaborations, And Other Recent Developments

  • Published : Mar 2020
  • Report Code : KSI061611421
  • Pages : 114

Offered with this report

Market Data

Market Data and Estimates in Excel

2 Months of Post Sale Analyst Support

2 Months of Post Sale Analyst Support

Requirement Specific Customization

Requirement Specific Customization

Neurofibromatosis Pipeline Analysis report covers 15 drugs currently in different phases of development. Neurofibromatosis is a genetic disorder characterised by formation of tumors on nerve tissue. There are 3 main types of neurofibromatosis: Neurofibromatosis type 1 (NF1), Neurofibromatosis type 2 (NF2) and Schwannomatosis. Neurofibromatosis type 1 (NF1) is the most common type of neurofibromatosis followed by NF2 and Schwannomatosis. Symptoms of the disease includes presence of café-au-lait spots, Lisch nodules, optic glioma, skeletal defects and freckling under the arms or in groin.

The report provides Neurofibromatosis treatment drugs by company, phases of development including products in early discovery stage and NDA filing, molecule type, route of administration and region. The report will help to evaluate the collaboration, in-licensing and out-licensing opportunities, formulating business development strategies and tracking the activities of the key market players. Epidemiology, major drivers, restraints, and opportunities have been covered to provide an exhaustive picture of the market. The analysis presents in-depth information regarding the development, trends, and industry policies and regulations implemented to offer stakeholders a better understanding of the key factors affecting the overall market environment.

Various databases (for patents and Clinical Trials), studies and data published by industry associations, analyst reports, investor presentations, press releases and journals among others have been taken into consideration while conducting the secondary research.

Market intelligence is presented in the form of analysis, charts, and graphics to help the clients in gaining faster and efficient understanding of the market.

Major industry players profiled as part of the report are Betta Pharmaceuticals Co.,Ltd., E.Z. BioXcel, Lixte Biotechnology Holdings, Inc. and Recursion Pharmaceuticals, Inc. among others.

Scope:

By Company

 

By Phase

NDA filed

Phase III

Phase II

Phase I

Pre-clinical

Discovery

 

By Molecule Type

Small molecules

Biologics

Peptides or Small proteins

 

By Region

North America

South America

Europe

Middle East and Africa

Asia Pacific

 

By Route of Administration

IV

IM

S/C

Oral

Intratumoral

1. Introduction 
1.1. Research Methodology
1.2. Research Scope
1.2.1. Analysis by Company
1.2.2. Analysis by Phase
1.2.3. By Molecule Type
1.2.4. By region
2. Disease Overview
2.1.1. Introduction
2.1.2. Classification
2.1.3. Symptoms
2.1.4. Causes
2.1.5. Diagnoses
2.1.6. Treatment
2.1.7. Epidemiology
3. Executive Summary
4. Market Dynamics
4.1. Drivers
4.2. Restraints
4.3. Opportunities
5. Pipeline Analysis/Outlook
5.1. Analysis by Company
5.2. Analysis by Phase
5.2.1. Phase of Development 
5.2.1.1. Introduction
5.2.1.1.1. Drug Profile
• Drug Name
• Generic Name
• Synonyms
• Company
• Collaborator
• Route of administration
• Target 
• Mechanism of Action
• Technology
• Molecule type
• CAS Number
• Weight
• Chemical Formula
• IUPAC name
• ATC code
5.2.1.1.2. Strategic Developments
5.2.1.1.3. Clinical trials
5.2.1.1.4. Clinical trial results
5.2.1.1.5. Patents
5.2.1.1.6. Technology
5.2.2. Comparative Analysis for Trials by Phase (Pie, Bar graph)
5.3. By Molecule type
5.4. Analysis by Region
6. Company profiling
6.1. Alexion
6.1.1. Introduction
6.1.2. Financials
6.1.3. Products and Services
6.1.4. SWOT
6.2. AstraZeneca
6.2.1. Introduction
6.2.2. Financials
6.2.3. Products and Services
6.2.4. SWOT
6.3. Betta Pharmaceuticals Co.,Ltd.
6.3.1. Introduction
6.3.2. Financials
6.3.3. Products and Services
6.3.4. SWOT
6.4. Celldex Therapeutics Inc
6.4.1. Introduction
6.4.2. Financials
6.4.3. Products and Services
6.4.4. SWOT
6.5. Daewon Pharmaceutical Co., Ltd.
6.5.1. Introduction
6.5.2. Financials
6.5.3. Products and Services
6.5.4. SWOT
6.6. E.Z. BioXcel
6.6.1. Introduction
6.6.2. Financials
6.6.3. Products and Services
6.6.4. SWOT
6.7. Genentech, Inc.
6.7.1. Introduction
6.7.2. Financials
6.7.3. Products and Services
6.7.4. SWOT
6.8. GL Pharm Tech Corporation
6.8.1. Introduction
6.8.2. Financials
6.8.3. Products and Services
6.8.4. SWOT
6.9. Lixte Biotechnology Holdings, Inc.
6.9.1. Introduction
6.9.2. Financials
6.9.3. Products and Services
6.9.4. SWOT
6.10. Novartis
6.10.1. Introduction
6.10.2. Financials
6.10.3. Products and Services
6.10.4. SWOT
6.11. Plex Pharmaceuticals
6.11.1. Introduction
6.11.2. Financials
6.11.3. Products and Services
6.11.4. SWOT
6.12. Recursion Pharmaceuticals, Inc.
6.12.1. Introduction
6.12.2. Financials
6.12.3. Products and Services
6.12.4. SWOT
6.13. Shandong Simcere-Medgenn Bio-pharmaceutical Co., Ltd
6.13.1. Introduction
6.13.2. Financials
6.13.3. Products and Services
6.13.4. SWOT
6.14. Synta Pharmaceuticals Corp.
6.14.1. Introduction
6.14.2. Financials
6.14.3. Products and Services
6.14.4. SWOT
6.15. The Butte Lab
6.15.1. Introduction
6.15.2. Financials
6.15.3. Products and Services
6.15.4. SWOT
List of Tables
List of Figures

Alexion

AstraZeneca

Betta Pharmaceuticals Co.,Ltd.

Celldex Therapeutics Inc

Daewon Pharmaceutical Co., Ltd.

E.Z. BioXcel

Genentech, Inc.

GL Pharm Tech Corporation

Lixte Biotechnology Holdings, Inc.

Novartis

Plex Pharmaceuticals

Recursion Pharmaceuticals, Inc.

Shandong Simcere-Medgenn Bio-pharmaceutical Co., Ltd

Synta Pharmaceuticals Corp.

The Butte Lab

Related Reports

Report Name Published Month Get Sample PDF
Telemedicine Market Size, Share & Growth: Report, 2021-2026 Aug 2021
Medical Electronics Market Size & Share: Report, 2022-2027 Nov 2022
Medical Tourism Market Size & Share: Industry Report, 2023 - 2028 May 2023
Optical Imaging Market Size & Share: Industry Report, 2022-2027 Dec 2022
Embolic Protection Devices Market Size: Report, 2021-2026 Dec 2021

License Type

$1750
$2350
$3000
$3600
$6000

Explore custom options available with this study

  • Customize this report
  • Buy sections of the study
  • Buy country specific report